An Efficient and Footprint-Free Protocol for the Transdifferentiation of Hepatocytes Into Insulin-Producing Cells With IVT mRNAs

Background Direct transdifferentiation of adult somatic cells into insulin-producing cells (IPCs) is a promising approach for cell-based therapies for type 1 diabetes mellitus. Liver cells are an ideal source for generating IPCs because they have regenerative ability and a developmental process similar to that of the pancreas. Pancreas versus liver fate is regulated by TALE homeoprotein (TGIF2) during development. Here, we wanted to investigate whether TGIF2 could enhance the efficiency of transdifferentiation of hepatocytes into IPCs induced by three pancreatic transcription factors (pTFs), i.e., Pdx1, NeuroD, and Mafa, which are crucial for pancreatic development in the embryo. Methods The in vitro transcribed (IVT) mRNAs of TGIF2 and the three pTFs were synthesized in vitro and sequentially supplemented in hepatocytes. On day 6, the expression of transcription factors was assessed by quantitative real-time polymerase chain reaction (qRT-PCR), and insulin expression was detected by immunofluorescence. Glucose-stimulated insulin secretion was assessed by enzyme-linked immunosorbent assay (ELISA). The key genes controlling cell polarity and the Wnt/PCP signaling pathway were assayed by qRT-PCR, and the level of JNK protein phosphorylation, which regulates the Wnt/PCP signaling pathway, was detected by western blotting. Results IVT mRNAs could be efficiently transfected into hepatocytes. Quantitative real-time polymerase chain reaction results revealed that compared with ectopic expression of the three pTFs alone, ectopic expression of the three pTFs plus TGIF2 could strongly reduce hepatic gene expression and subsequently improve the induction of a set of pancreatic genes. Immunofluorescence analysis showed that TGIF2 expression could double the transdifferentiation yield; 30% of the cells were insulin positive if induced by TGIF2 plus the 3 pTFs, while only 15% of the cells were insulin positive if induced by the three pTFs alone. ELISA analysis confirmed that glucose-stimulated insulin secretion was less efficient after transfection with the three pTFs alone. The differentiated cells derived from the addition of TGIF2 mRNA could form islet-like clusters. By contrast, the cells differentiated with the three pTFs did not form clusters under the same conditions. Tgif2 induced transdifferentiation more efficiently by remodeling the expression of genes in the Wnt/PCP pathway. Overexpression of TGIF2 in hepatocytes could activate the expression of key genes controlling cell polarity and genes in the Wnt/PCP signaling pathway, increasing the level of JNK protein phosphorylation. Conclusions Our study established a novel footprint-free protocol for efficient transdifferentiation of hepatocytes into IPCs using IVT mRNAs of TGIF2 and 3 pTFs, which paved the way toward a clinical application.

[1]  E. Tai,et al.  New insights into human beta cell biology using human pluripotent stem cells. , 2019, Seminars in cell & developmental biology.

[2]  S. Shalitin,et al.  Type 1 diabetes mellitus management in young children: implementation of current technologies , 2019, Pediatric Research.

[3]  J. Ciriza,et al.  Review of Advanced Hydrogel-Based Cell Encapsulation Systems for Insulin Delivery in Type 1 Diabetes Mellitus , 2019, Pharmaceutics.

[4]  S. Ferber,et al.  Liver to Pancreas Transdifferentiation , 2019, Current Diabetes Reports.

[5]  M. Ko,et al.  Establishment of a rapid and footprint-free protocol for differentiation of human embryonic stem cells into pancreatic endocrine cells with synthetic mRNAs encoding transcription factors , 2018, Stem Cell Research & Therapy.

[6]  E. Pone,et al.  Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes , 2018, Front. Immunol..

[7]  Y. Ikeda,et al.  PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration , 2017, Stem Cell Research & Therapy.

[8]  F. Avolio,et al.  β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma” , 2017, Front. Genet..

[9]  Yong Wang,et al.  Islet Microencapsulation: Strategies and Clinical Status in Diabetes , 2017, Current Diabetes Reports.

[10]  Dongjun Liu,et al.  Effect of Wnt Signaling on the Differentiation of Islet β-Cells from Adipose-Derived Stem Cells , 2017, BioMed research international.

[11]  E. Bonifacio,et al.  Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2 , 2017, Nature Communications.

[12]  JG Allickson Emerging Translation of Regenerative Therapies , 2017, Clinical pharmacology and therapeutics.

[13]  S. Ferber,et al.  Reprogramming of liver cells into insulin-producing cells. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[14]  J. Rosenecker,et al.  Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration , 2015, PloS one.

[15]  D. S. Li,et al.  Gene Manipulation of Human Embryonic Stem Cells by In Vitro-Synthesized mRNA for Gene Therapy. , 2015, Current gene therapy.

[16]  A. Wrońska,et al.  In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells. , 2015, Folia histochemica et cytobiologica.

[17]  Bo Kara,et al.  The translation of cell-based therapies: clinical landscape and manufacturing challenges. , 2015, Regenerative medicine.

[18]  Satoru Takahashi,et al.  Generation of Insulin-Producing Cells from the Mouse Liver Using β Cell-Related Gene Transfer Including Mafa and Mafb , 2014, PloS one.

[19]  Dong Sheng Li,et al.  Reprogramming human umbilical cord mesenchymal stromal cells to islet-like cells with the use of in vitro-synthesized pancreatic-duodenal homebox 1 messenger RNA. , 2014, Cytotherapy.

[20]  Irit Meivar-Levy,et al.  The Temporal and Hierarchical Control of Transcription Factors-Induced Liver to Pancreas Transdifferentiation , 2014, PloS one.

[21]  H. Kaneto,et al.  Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. , 2009, Current medicinal chemistry.

[22]  A. Brivanlou,et al.  The Gata5 target, TGIF2, defines the pancreatic region by modulating BMP signals within the endoderm , 2008, Development.

[23]  M. Hamid,et al.  COMPARISON OF THE SECRETORY PROPERTIES OF FOUR INSULIN-SECRETING CELL LINES , 2002, Endocrine research.

[24]  M. Atkinson,et al.  Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes. , 2013, American journal of translational research.